Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen replacement therapy and stroke

A Paganini-Hill1

  • 1Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 90031, USA.

Progress in Cardiovascular Diseases
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prior endogenous and exogenous estrogen and incident dementia in the 10th decade of life: The 90+ Study.

Climacteric : the journal of the International Menopause Society·2020
Same author

Subcortical Magnetic Resonance Imaging Changes in a Healthy Elderly Population; Stroke Risk Factors, Ultrasound, and Hemostasis Findings.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2016
Same author

Association of male circumcision with risk of prostate cancer: a meta-analysis.

Prostate cancer and prostatic diseases·2015
Same author

Estrogen in the treatment and prevention of Alzheimer's disease.

International journal of pharmaceutical compounding·2013
Same author

Prevalence of dementia after age 90: results from the 90+ study.

Neurology·2008
Same author

Change in mandibular trabecular pattern and hip fracture rate in elderly women.

Dento maxillo facial radiology·2005
Same journal

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Progress in cardiovascular diseases·2026
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
See all related articles

Estrogen replacement therapy may reduce stroke death risk, but evidence on preventing strokes is conflicting. More research is needed to clarify estrogen

Area of Science:

  • Neurology
  • Endocrinology
  • Epidemiology

Background:

  • Estrogen replacement therapy (ERT) is widely used, but its association with cerebrovascular disease remains debated.
  • Previous studies on ERT and stroke risk have yielded inconsistent results.
  • Understanding ERT's impact on brain health is crucial for patient care.

Purpose of the Study:

  • To synthesize findings from 19 studies on ERT and cerebrovascular disease.
  • To evaluate the association between ERT and stroke mortality versus incident stroke.
  • To identify gaps in knowledge regarding ERT's effects on stroke risk.

Main Methods:

  • Systematic review and meta-analysis of 19 observational studies.
  • Analysis of studies reporting on stroke death, incident stroke, and subarachnoid hemorrhage.

Related Experiment Videos

  • Assessment of risk ratios (RRs) for estrogen users versus nonusers.

    • Main Results:

    • Seven studies on stroke death consistently showed a 20%-60% risk reduction with ERT.
    • Studies on incident stroke and subarachnoid hemorrhage presented conflicting results, with RRs ranging from 0 to 2.3.
    • Limited and contradictory data exist on optimal estrogen dose, duration, and discontinuation.

    Conclusions:

    • While ERT may reduce stroke mortality, its effect on preventing strokes is uncertain due to conflicting evidence.
    • Further research is required to elucidate ERT's biological mechanisms, optimal usage parameters, and interactions with other factors.
    • High-quality studies are needed to address biases and confounding factors in current research.